BARTLETT & CO. WEALTH MANAGEMENT LLC
Position in CADL — Candel Therapeutics, Inc.
CIK 2010186
CINCINNATI, OH
Position in CADL
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$17,248
New position
Shares Held
3,520
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 50.ToString("F0")%
Shared 0.ToString("F0")%
None 50.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARTLETT & CO. WEALTH MANAGEMENT LLC holds $1,178,544 across 17 Biotechnology names. CADL ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
11,100 | $528,027 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
362 | $279,695 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
570 | $254,527 | |
| 4 | INCY |
Incyte Corp
|
354 | $33,318 | |
| 5 | DNLI |
Denali Therapeutics Inc.
|
1,500 | $28,800 | |
| 6 | CADL |
Candel Therapeutics, Inc.
This page
|
3,520 | $17,248 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
1,071 | $10,088 | |
| 8 | OCGN |
Ocugen, Inc.
|
5,300 | $9,593 |
All Filings in CADL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,248 | 3,520 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||